Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Training Model to Advance Support of the Family as a Caregiving System in the Inpatient Oncology Setting

Not Applicable

Active, not recruiting

Conditions: Support of the Family as a Caregiving System

Interventions: Behavioral: Working with the Caregiving Family (WCF) training
Behavioral: questionnaires

First Posted Date: 2013-03-06

Last Posted Date: 2025-03-04

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 80

Registration Number: NCT01805609

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Community Primary Care Providers to Implement and Disseminate Cancer Prevention Interventions for Latino Populations

Terminated

Conditions: For New York State Registered Family Practitioners and Internal Medicine Physicians

Interventions: Behavioral: in-depth, semi-structured interviews

First Posted Date: 2013-03-04

Last Posted Date: 2015-02-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 3

Registration Number: NCT01803750

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

QOL Assessment in Breast Cancer Patients With Radiation-Induced Telangiectasias Treated With the Pulsed Dye Laser

Completed

Conditions: Breast Cancer
Radiation-Induced Telangiectasias

Interventions: Behavioral: questionnaires

First Posted Date: 2013-03-04

Last Posted Date: 2018-02-07

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 22

Registration Number: NCT01803516

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Vemurafenib and Panitumumab Combination Therapy in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer

Phase 1

Completed

Conditions: Metastatic Colorectal Cancer

Interventions: Drug: combination panitumumab and vemurafenib

First Posted Date: 2013-02-13

Last Posted Date: 2016-01-05

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 16

Registration Number: NCT01791309

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Longitudinal Sexual and Reproductive Health Study of Women with Breast Cancer and Lymphoma

Recruiting

Conditions: Breast Cancer
Lymphoma
Hodgkin's Lymphoma

Interventions: Behavioral: surveys
Other: Blood draw
Device: Transvaginal ultrasounds

First Posted Date: 2013-02-11

Last Posted Date: 2025-03-26

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 425

Registration Number: NCT01788839

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States

and more 4 locations

Genomic Profiling in Cancer Patients

Recruiting

Conditions: Solid Tumors
Hematologic Cancers

Interventions: Genetic: molecular profiling of tumors
Genetic: Clinical Germline Analysis

First Posted Date: 2013-01-24

Last Posted Date: 2025-05-22

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 200

Registration Number: NCT01775072

Locations: 🇺🇸
Norwalk Hospital, Norwalk, Connecticut, United States
🇺🇸
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
🇺🇸
Lehigh Valley Health Network, Allentown, Pennsylvania, United States

and more 15 locations

Group Interventions for Breast Cancer Survivors

Not Applicable

Active, not recruiting

Conditions: Breast Cancer Survivor

Interventions: Behavioral: manualized group intervention
Behavioral: standardized, manualized group intervention

First Posted Date: 2013-01-24

Last Posted Date: 2025-02-04

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 104

Registration Number: NCT01775085

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center at Commack, Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Study of 89Zr-DFO-MSTP2109A in Patients With Prostate Cancer

Phase 1

Completed

Conditions: Prostate Cancer

Interventions: Drug: 89Zr- DFO-MSTP2109A
Drug: 89Zr DFO-MSTP2109A

First Posted Date: 2013-01-23

Last Posted Date: 2024-10-02

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 19

Registration Number: NCT01774071

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Clinical and Histopathologic Characteristics of BAP1 Mutations

Completed

Conditions: Primary Uveal Melanoma (UM)
Choroidal Nevus
Metastatic Uveal Melanoma (UM)
Renal Cell Carcinoma
Malignant Pleural Mesothelioma (MPM)
Cholangiocarcinoma

Interventions: Other: tumor specimens

First Posted Date: 2013-01-23

Last Posted Date: 2020-07-01

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 196

Registration Number: NCT01773655

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States

Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Phase 2

Active, not recruiting

Conditions: Fallopian Tubes Cancer
Ovarian Cancer
Peritoneal Cancer

Interventions: Procedure: Secondary Cytoreductive Surgery
Drug: Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Drug: platinum-based systemic chemotherapy postoperatively

First Posted Date: 2013-01-14

Last Posted Date: 2025-02-04

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 99

Registration Number: NCT01767675

Locations: 🇺🇸
Memorial Sloan Kettering Commack, Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

and more 8 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy